Stephen J. Blakemore,Alessandra M. Di Bacco,George J. Mulligan
申请号：
US15614745
公开号：
US20180117069A1
申请日:
2017.06.06
申请国别(地区):
US
年份:
2018
代理人:
摘要：
The present invention provides a method of treating cancer with a proteasome inhibitor. The invention also provides a method of treating a patient with cancer based on elevated expression levels of NFκB, as measured by a H-score of the patients tumor sample using a NFκB p65 IHC assay. The invention also provides a method of determining whether to treat a patient with a proteasome inhibitor based on the level of NFκB p65 in the patients tumor sample.
